Planning and Conducting the ISCHEMIA Trial.
作者信息
Maron David J, Harrington Robert A, Hochman Judith S
机构信息
Department of Medicine, Stanford University School of Medicine, CA (D.J.M., R.A.H.).
Department of Medicine, New York University School of Medicine, New York, NY (J.S.H.).
出版信息
Circulation. 2018 Oct 2;138(14):1384-1386. doi: 10.1161/CIRCULATIONAHA.118.036904.
Abstract
摘要
相似文献
1
Planning and Conducting the ISCHEMIA Trial.规划与开展“国际多中心缺血性心脏病优化治疗策略研究（ISCHEMIA）试验”
Circulation. 2018 Oct 2;138(14):1384-1386. doi: 10.1161/CIRCULATIONAHA.118.036904.
2
ISCHEMIA: Establishing the Primary End Point.缺血：确立主要终点
Circ Cardiovasc Qual Outcomes. 2018 May;11(5):e004791. doi: 10.1161/CIRCOUTCOMES.118.004791.
3
BARI 2D: headlines are not enough.BARI 2D：仅看标题是不够的。
JACC Cardiovasc Interv. 2009 Aug;2(8):809-10. doi: 10.1016/j.jcin.2009.06.007.
4
The ISCHEMIA Trial Meets the Rashomon Effect: Lessons for Clinical Practice.缺血性心脏病优化药物治疗与介入治疗比较疗效研究（ISCHEMIA）试验呈现“罗生门效应”：临床实践的经验教训
Circ Cardiovasc Qual Outcomes. 2020 Feb;13(2):e006527. doi: 10.1161/CIRCOUTCOMES.120.006527. Epub 2020 Feb 17.
5
Conservative versus invasive stable ischemic heart disease management strategies: what do we plan to learn from the ISCHEMIA trial?保守治疗与侵入性治疗稳定型缺血性心脏病的管理策略：我们计划从缺血性心脏病优化药物和介入治疗策略比较有效性研究（ISCHEMIA）试验中学到什么？
Future Cardiol. 2016 Jan;12(1):35-44. doi: 10.2217/fca.15.57. Epub 2015 Dec 21.
6
Secondary prevention of ischaemic cardiac events.缺血性心脏事件的二级预防。
Clin Evid. 2002 Jun(7):124-60.
7
Revascularization vs. Medical Therapy in Stable Ischemic Heart Disease.稳定型缺血性心脏病的血运重建与药物治疗对比
Prog Cardiovasc Dis. 2015 Nov-Dec;58(3):299-305. doi: 10.1016/j.pcad.2015.07.005. Epub 2015 Jul 21.
8
The role of ISCHEMIA in stable ischemic heart disease.ISCHEMIA 在稳定型缺血性心脏病中的作用。
Cleve Clin J Med. 2020 Jun 30;87(7):401-409. doi: 10.3949/ccjm.87a.20033.
9
ISCHEMIA: new questions from a landmark trial.缺血：一项具有里程碑意义的试验带来的新问题
Cardiovasc Res. 2020 Feb 1;116(2):e23-e25. doi: 10.1093/cvr/cvz343.
10
Therapeutic strategies in patients with chronic stable coronary artery disease.慢性稳定性冠状动脉疾病患者的治疗策略。
Cardiovasc Ther. 2011 Dec;29(6):e23-30. doi: 10.1111/j.1755-5922.2010.00164.x. Epub 2010 May 13.
引用本文的文献
1
A conversation with Dr. David J. Maron, Director of Preventive Cardiology at Stanford Hospital and Clinics.与斯坦福医院及诊所预防心脏病学主任大卫·J·马龙医生的一次对话。
J Clin Transl Sci. 2022 Dec 27;6(1):e139. doi: 10.1017/cts.2022.458. eCollection 2022.
2
Ischemia Trial: Does the Cardiology Community Need to Pivot or Continue Current Practices?缺血试验：心血管学界需要转变还是继续当前的做法？
Curr Cardiol Rep. 2022 Aug;24(8):1059-1068. doi: 10.1007/s11886-022-01725-1. Epub 2022 Jun 2.
3
ISCHEMIA Trial: Key Questions and Answers.缺血试验：关键问题与解答。
Eur Cardiol. 2021 Sep 14;16:e34. doi: 10.15420/ecr.2021.16. eCollection 2021 Feb.
4
The ISCHEMIA Trial: And the Winner Is… the Patient.缺血性心脏病优化药物与介入治疗比较有效性研究（ISCHEMIA）试验：赢家是……患者。
Eur Cardiol. 2021 Mar 30;16:e10. doi: 10.15420/ecr.2021.03. eCollection 2021 Feb.
5
Coronary Revascularization and Long-Term Survivorship in Chronic Coronary Syndrome.慢性冠状动脉综合征中的冠状动脉血运重建与长期生存
J Clin Med. 2021 Feb 5;10(4):610. doi: 10.3390/jcm10040610.
6
The legacy of ISCHEMIA.缺血性心脏病（ISCHEMIA）试验的遗留影响
Cardiol J. 2020;27(4):329-335. doi: 10.5603/CJ.2020.0108.
7
Coronary F-Sodium Fluoride Uptake Predicts Outcomes in Patients With Coronary Artery Disease.冠状动脉 F 型钠-氟化物摄取可预测冠状动脉疾病患者的结局。
J Am Coll Cardiol. 2020 Jun 23;75(24):3061-3074. doi: 10.1016/j.jacc.2020.04.046.
8
Initial Invasive or Conservative Strategy for Stable Coronary Disease.稳定型冠心病的初始侵入性或保守治疗策略。
N Engl J Med. 2020 Apr 9;382(15):1395-1407. doi: 10.1056/NEJMoa1915922. Epub 2020 Mar 30.
9
Survival analysis (Kaplan-Meier curves): a method to predict the future.生存分析（Kaplan-Meier曲线）：一种预测未来的方法。
Arq Bras Oftalmol. 2020 Mar-Apr;83(2):V-VII. doi: 10.5935/0004-2749.20200036.
10
Current approach to the diagnosis of atherosclerotic coronary artery disease: more questions than answers.当前动脉粥样硬化性冠状动脉疾病的诊断方法：问题多于答案。
Ther Adv Chronic Dis. 2019 Nov 1;10:2040622319884819. doi: 10.1177/2040622319884819. eCollection 2019.
本文引用的文献
1
International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) trial: Rationale and design.国际比较医疗与介入治疗缺血效果研究（ISCHEMIA）试验：原理与设计。
Am Heart J. 2018 Jul;201:124-135. doi: 10.1016/j.ahj.2018.04.011. Epub 2018 Apr 21.
2
2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons.2012年美国心脏病学会基金会/美国心脏协会实践指南工作组、美国内科医师学会、美国胸外科协会、心血管护理预防协会、心血管造影和介入学会以及胸外科协会关于稳定型缺血性心脏病患者诊断和管理的指南
Circulation. 2012 Dec 18;126(25):e354-471. doi: 10.1161/CIR.0b013e318277d6a0. Epub 2012 Nov 19.
3
Impact of ischaemia and scar on the therapeutic benefit derived from myocardial revascularization vs. medical therapy among patients undergoing stress-rest myocardial perfusion scintigraphy.在接受应激-静息心肌灌注闪烁显像的患者中，缺血和瘢痕对经皮冠状动脉介入治疗与药物治疗的疗效的影响。
Eur Heart J. 2011 Apr;32(8):1012-24. doi: 10.1093/eurheartj/ehq500. Epub 2011 Jan 21.
4
Ethnic differences in the prognostic value of stress technetium-99m tetrofosmin gated single-photon emission computed tomography myocardial perfusion imaging.应激锝-99m 替曲膦门控单光子发射计算机断层扫描心肌灌注成像预后价值的种族差异
J Am Coll Cardiol. 2005 May 3;45(9):1494-504. doi: 10.1016/j.jacc.2005.01.036.
Zotero 插件